
Burning Rock Biotech Limited Market Cap | BNR
As of November 19, 2026 Burning Rock Biotech Limited has a market cap of $ 135 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Burning Rock Biotech Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 2.95 B | - | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.95 B | 2.95 B | 2.95 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Diagnostics research industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Renalytix AI plc
RNLX
|
22.7 M | - | 5.66 % | $ 22.7 M | ||
|
DexCom
DXCM
|
25.5 B | $ 82.53 | 0.6 % | $ 32.2 B | ||
|
Meridian Bioscience
VIVO
|
1.38 B | - | - | $ 1.49 B | ||
|
Heska Corporation
HSKA
|
844 M | - | - | $ 1.31 B | ||
|
Accelerate Diagnostics
AXDX
|
4.03 M | - | -61.36 % | $ 2.46 M | ||
|
Celcuity
CELC
|
5.37 B | $ 55.51 | -3.86 % | $ 2.6 B | ||
|
T2 Biosystems
TTOO
|
7.78 M | - | -39.35 % | $ 313 K | ||
|
Syneos Health
SYNH
|
9.41 B | - | - | $ 4.46 B | ||
|
Biocept
BIOC
|
5.93 M | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
511 M | - | - | $ 21.2 M | ||
|
Quotient Limited
QTNT
|
237 M | - | -11.32 % | $ 1.1 M | ||
|
DermTech
DMTK
|
42.4 M | - | -11.32 % | $ 2.94 M | ||
|
Surmodics
SRDX
|
554 M | - | - | $ 608 M | ||
|
Brainsway Ltd.
BWAY
|
301 M | $ 9.02 | -1.04 % | $ 306 M | ||
|
Akumin
AKU
|
75.1 M | - | -17.87 % | $ 25.9 M | ||
|
Psychemedics Corporation
PMD
|
16.8 M | - | -1.84 % | $ 15.3 M | ||
|
Danaher Corporation
DHR
|
150 B | $ 228.43 | 1.18 % | $ 163 B | ||
|
Chembio Diagnostics
CEMI
|
12.6 M | - | 0.22 % | $ 16.8 M | ||
|
Motus GI Holdings
MOTS
|
990 K | - | -34.28 % | $ 263 K | ||
|
HTG Molecular Diagnostics
HTGM
|
2.99 M | - | -20.0 % | $ 1.06 M | ||
|
Anixa Biosciences
ANIX
|
104 K | $ 2.72 | 1.87 % | $ 88.3 K | ||
|
Biodesix
BDSX
|
113 M | $ 8.42 | -5.18 % | $ 63.6 M | ||
|
Agilent Technologies
A
|
31.5 B | $ 176.32 | 2.38 % | $ 50.1 B | ||
|
BioNano Genomics
BNGO
|
7.95 M | $ 0.98 | 3.13 % | $ 5.34 M | ||
|
Bioventus
BVS
|
608 M | $ 10.64 | 0.38 % | $ 709 M | ||
|
Quest Diagnostics Incorporated
DGX
|
23.3 B | $ 259.18 | 1.1 % | $ 28.8 B | ||
|
Charles River Laboratories International
CRL
|
7.69 B | $ 333.37 | 0.36 % | $ 16.5 B | ||
|
Guardant Health
GH
|
13.4 B | $ 145.11 | 1.28 % | $ 18.2 B | ||
|
Castle Biosciences
CSTL
|
472 M | $ 33.41 | 1.3 % | $ 968 M | ||
|
Illumina
ILMN
|
25.3 B | $ 209.18 | 3.24 % | $ 32.4 B | ||
|
IQVIA Holdings
IQV
|
28.3 B | $ 257.93 | 0.13 % | $ 44.3 B | ||
|
Laboratory Corporation of America Holdings
LH
|
23.9 B | $ 370.49 | 0.61 % | $ 30.8 B | ||
|
IDEXX Laboratories
IDXX
|
51.1 B | $ 700.79 | 1.53 % | $ 56.4 B | ||
|
Medpace Holdings
MEDP
|
13 B | $ 647.03 | -0.93 % | $ 18.7 B | ||
|
Mettler-Toledo International
MTD
|
28.4 B | $ 1 734.36 | 1.25 % | $ 35.7 B | ||
|
Natera
NTRA
|
30.5 B | $ 286.77 | -0.25 % | $ 39.2 B | ||
|
Lantheus Holdings
LNTH
|
5.12 B | $ 102.03 | 0.23 % | $ 6.89 B | ||
|
Fulgent Genetics
FLGT
|
527 M | $ 25.14 | 3.84 % | $ 774 M | ||
|
CareDx, Inc
CDNA
|
993 M | $ 74.4 | -0.21 % | $ 3.96 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
421 M | - | - | $ 562 M | ||
|
Biomerica
BMRA
|
6.09 M | $ 1.15 | -6.88 % | $ 3.35 M | ||
|
Interpace Biosciences
IDXG
|
7.34 M | $ 5.44 | -9.42 % | $ 24.1 M | ||
|
Fluidigm Corporation
FLDM
|
481 M | - | 1.08 % | $ 308 M | ||
|
ICON Public Limited Company
ICLR
|
10.1 B | $ 194.96 | -0.03 % | $ 15.3 B | ||
|
Senseonics Holdings
SENS
|
351 M | $ 9.76 | -3.99 % | $ 407 M | ||
|
Sotera Health Company
SHC
|
4.75 B | $ 16.27 | 1.34 % | $ 4.62 B | ||
|
Co-Diagnostics
CODX
|
5.85 M | $ 0.2 | 1.99 % | $ 266 K | ||
|
Precipio
PRPO
|
38.4 M | $ 18.8 | -1.93 % | $ 30.2 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
7.87 B | - | - | $ 10.7 B |